NAGE

Niagen Bioscience

75 hedge funds and large institutions have $25.3M invested in Niagen Bioscience in 2022 Q2 according to their latest regulatory filings, with 15 funds opening new positions, 21 increasing their positions, 25 reducing their positions, and 19 closing their positions.

New
Increased
Maintained
Reduced
Closed

more funds holding in top 10

Funds holding in top 10:

less ownership

Funds ownership:

less funds holding

Funds holding:

less call options, than puts

Call options by funds: $ | Put options by funds: $

16% less repeat investments, than reductions

Existing positions increased: 21 | Existing positions reduced: 25

21% less first-time investments, than exits

New positions opened: 15 | Existing positions closed: 19

49% less capital invested

Capital invested by funds: $49.9M → $25.3M (-$24.6M)

Holders
75
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$100K
Puts
$117K
Net Calls
Net Calls Change

Top Buyers

1 +$1.43M
2 +$1.27M
3 +$534K
4
Citadel Advisors
Citadel Advisors
Florida
+$441K
5
E
Ergoteles
New York
+$385K

Top Sellers

1 -$3.62M
2 -$2.28M
3 -$1.88M
4
Bank of America
Bank of America
North Carolina
-$1.27M
5
State Street
State Street
Massachusetts
-$1.16M
Name Holding Trade Value Shares
Change
Change in
Stake
26
$76K
27
$75K
28
$68K
29
$67K
30
$65K
31
$64K
32
$63K
33
$61K
34
$56K
35
$47K
36
$46K
37
$44K
38
$42K
39
$41K
40
$40K
41
$40K
42
$39K
43
$38K
44
$38K
45
$35K
46
$32K
47
$30K
48
$30K
49
$28K
50
$28K